Aspen Australia
- Company typePrivate
- Founded2001
- HeadquartersCity Of Sydney, Australia
- Headcount5,001–10,000
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
Aspen Australia firmographics
Firmographics- Name
- Aspen Australia
- Legal name
- Aspen Pharmacare Australia Pty Ltd
- Website
- https://aspenpharma.com.au
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Ownership category
- akta.pro rank
Aspen Australia industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- OTC & Consumer Health Distributors (HLAIAJAC)
- akta.pro secondary industries
- Cold, Flu & Cough Remedies (HLAIADAB), Allergy, Sinus & Respiratory (Non-Asthma) (HLAIADAC), Pain Relief & Anti-Inflammatory (Analgesics) (HLAIADAA), Sleep, Stress & Mood Support (HLAIADAG)
Keywords
Where Aspen Australia is headquartered
LocationHeadquarters
- HQ city
- City Of Sydney
- HQ country
- Australia
- HQ region
- Oceania
Offices8 records
Markets served
Aspen Australia business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations
Revenue model
- Prescription Medicines Sales: Sale of prescription medicines across therapeutic areas including anaesthetics, mental health, paediatric health, womens and mens health, dermatology, endocrinology, metabolic diseases, infectious diseases, ophthalmology, and analgesics.
- Consumer OTC Products: Sale of over-the-counter consumer healthcare brands including products for womens health, digestive health, pain management, nasal and sinus care, skin care, heart health, specialty formula, and sleep health.
- Contract Manufacturing Services: Provides contract manufacturing services to external partners at Dandenong facility in addition to Aspen's own products.
- Licensing and Distribution Partnerships: In-licensing high-potential products and expanding market reach. Distribution partnerships for export to Europe, Asia Pacific, Middle East, and Indian Ocean region.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
Aspen Australia product offering
Product offeringCore offering
Aspen Australia manufactures and supplies a diversified portfolio of prescription medicines and over-the-counter (OTC) consumer health products across multiple therapeutic areas including anaesthetics, mental health, dermatology, endocrinology, ophthalmology, and analgesics. The company operates a GMP/TGA-licensed manufacturing facility in Dandenong, Victoria producing solid and liquid dosage forms and medical devices for domestic Australian and international export markets.
Product overview
Aspen Pharmacare Australia is one of Australia's leading pharmaceutical companies offering a diversified portfolio of prescription and over-the-counter (OTC) consumer medicine brands. The company operates across three core business segments: Prescription Medicines (covering therapeutic areas including anaesthetics, mental health, paediatric health, women's/men's health, dermatology, endocrinology, metabolic diseases, infectious diseases, ophthalmology, and analgesics), Consumer OTC brands (including Bio-Oil, Cartia, Circadin, Coloxyl, Dermeze, Emla, FLO, Gastro-Stop, GOUT Shield, Imigran Migraine, Kenalog in Orabase, LARRI, LOGICIN, Maltofer, Novalac, Remifemin, Sigmacort, Stingose, Ural, Xylocaine, Zantac, and Zanzole), and Manufacturing Operations (with a GMP/TGA licensed facility in Dandenong, Victoria producing solids, liquids, and medical devices). The portfolio spans approximately 150+ prescription and OTC brands.
Differentiator
Problem solved
Functional benefit
Products and services
- Prescription Medicines Portfolio Comprehensive portfolio of prescription medicines covering therapeutic areas including anaesthetics, mental health, paediatric health, women's and men's health, dermatology, endocrinology, metabolic diseases, infectious diseases, ophthalmology, and analgesics. Distributed to healthcare professionals, hospital pharmacists, and pharmacies across Australia and New Zealand.
- Consumer OTC Portfolio Over-the-counter consumer medicine brands addressing everyday health concerns including women's health, digestive health, pain management, nasal and sinus care, skin care, heart health, specialty formula, and sleep health. Marketed through pharmacy retail channels to end consumers. Includes brands such as Bio-Oil, Cartia, Circadin, Coloxyl, Emla, FLO, Gastro-Stop, Imigran Migraine, and Maltofer.
- Manufacturing Operations Pharmaceutical manufacturing services at the Dandenong, Victoria facility producing solid dose forms (tablets, powders, capsules) and liquid dosage forms (suspensions, ointments, creams) plus medical devices. Accredited with GMP, TGA and ISO certifications. Products manufactured for both Aspen's own portfolio and contract manufacturing clients.
- Contract Manufacturing Services Contract manufacturing services provided at the Dandenong, Victoria facility to external pharmaceutical partners requiring solid and liquid dosage form manufacturing, regulatory support, and commercialisation expertise. Used by multinational pharmaceutical companies seeking Australian/NZ market entry.
- Licensing and Distribution Partnerships In-licensing of high-potential products and distribution partnership arrangements enabling multinational pharmaceutical companies to reach Australian, New Zealand, and Asia Pacific markets through Aspen's regulatory, market access, and commercial execution expertise. Distribution partnerships also support exports to Europe, Asia Pacific, Middle East, and Indian Ocean region.
Companies that use Aspen Australia
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Aspen Australia technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Aspen Australia partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered minor and core.
- OzHarvestminorCommunity partnership supporting food rescue and sustainability. Aspen Australia volunteers involved in production of hundreds of meals delivered to local charities across Australia and New Zealand.
- Fair Food NZminorNew Zealand partner for food rescue and sustainability. Aspen Australia volunteers involved in production of meals delivered to local charities.
- R U OK?minorNational suicide prevention charity partnership. Aspen Australia runs annual week-long awareness campaign focusing on mental health and checking in with one another.
- International Pharmaceutical PartnerscoreLong-standing commercial partnerships with multinational pharmaceutical companies for product licensing, distribution, and contract manufacturing. Partners benefit from Aspen's regulatory strategy, market access, and commercial execution expertise.
Scale indicators5 records
Recent moves8 records
Expansion highlights6 records
Aspen Australia competitors and assessment
Company assessmentDirect peers
- Blackmores Limited: Australia's leading natural health and consumer health company with branded supplements and OTC products. Comparable to Aspen Australia's OTC consumer brand business, particularly in pharmacy channels and Australian consumer health portfolio.
- Mayne Pharma Group: Australian specialty pharmaceutical manufacturer and distributor with a comparable model combining own-branded generics, contract manufacturing, and consumer health products. Operates Australian manufacturing capacity and competes directly with Aspen Australia in prescription and specialty pharma.
- Ego Pharmaceuticals: Australian-owned pharmaceutical manufacturer specialising in dermatology and OTC skincare brands. Comparable to Aspen Australia in the Australian OTC consumer health segment with manufacturing operations and branded pharmacy distribution.
Broad incumbents
- Pfizer Australia: Australian subsidiary of one of the world's largest pharmaceutical companies. Comparable to Aspen Australia in the Australian prescription and consumer health market, and has historically partnered with Aspen via in-licensing arrangements for products such as Lipitor.
- Novartis Australia: Australian subsidiary of Swiss pharmaceutical major Novartis with prescription medicines across multiple therapeutic areas. Comparable to Aspen Australia as a multinational pharma company competing in the Australian prescription and specialty medicines market.
- Sanofi Australia: Australian subsidiary of global pharmaceutical major with prescription medicines, vaccines, and consumer health products. Comparable to Aspen Australia as a multinational pharma presence serving Aus/NZ with diversified prescription and OTC offerings.
- Bayer Australia: Local subsidiary of global pharmaceutical major with both prescription and consumer health (OTC) products distributed in Australia. Comparable to Aspen Australia as a multinational pharmaceutical player in the Australian market across Rx and OTC.
- GSK Australia: Australian arm of GlaxoSmithKline with vaccines, prescription pharmaceuticals, and consumer healthcare products. Comparable to Aspen Australia in Australian pharma distribution and as a historical licensing partner for several Aspen Australia brands.
- CSL Limited: Australia's largest biopharmaceutical company, also ASX-listed. Comparable to Aspen Australia as a major Australian-headquartered pharma operator with global reach, manufacturing, and branded pharmaceutical products, though CSL is plasma-derived/biologics focused.
Emerging players
- Arrotex Pharmaceuticals: Australia's largest generic pharmaceutical company with branded and generic medicines across multiple therapeutic categories. Comparable to Aspen Australia's prescription and OTC portfolio with growing Australian manufacturing and licensing activity.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights6 records
Customer concentration
Aspen Australia social profiles
Digital presenceAspen Australia compliance and trust
Trust signalCompliance5 records
Aspen Australia financial estimates
Financial estimateRevenue estimate
Valuation estimate
Aspen Australia leadership team
Management profileNumber of profiles
Aspen Australia subsidiaries and ownership
Company hierarchySubsidiaries6 records
Aspen Australia funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Aspen Australia M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Aspen Australia
What does Aspen Australia do?
Aspen Australia manufactures and supplies a diversified portfolio of prescription medicines and over-the-counter (OTC) consumer health products across multiple therapeutic areas including anaesthetics, mental health, dermatology, endocrinology, ophthalmology, and analgesics. The company operates a GMP/TGA-licensed manufacturing facility in Dandenong, Victoria producing solid and liquid dosage forms and medical devices for domestic Australian and international export markets.
Is Aspen Australia a public or private company?
Aspen Australia is a private company. It is classified as corporate owned and is currently operating.
When was Aspen Australia founded?
Aspen Australia was founded in 2001. It employs 5,001 to 10,000 people.
Where is Aspen Australia based?
Aspen Australia is headquartered in City Of Sydney, Australia, in the Oceania region.
How does Aspen Australia make money?
Four revenue lines are on record. Prescription Medicines Sales are the primary driver. The others are consumer OTC Products, contract Manufacturing Services and licensing and Distribution Partnerships.
Who are Aspen Australia's main competitors?
Direct peers on record are Blackmores Limited, Mayne Pharma Group and Ego Pharmaceuticals. Broad incumbents are Pfizer Australia, Novartis Australia, Sanofi Australia, Bayer Australia, GSK Australia and CSL Limited. Arrotex Pharmaceuticals is listed as an emerging player.
Does Aspen Australia have an API?
No public API is recorded for Aspen Australia.
What industry is Aspen Australia in?
Aspen Australia's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAJAC, OTC & Consumer Health Distributors, with a secondary code of HLAIADAB, Cold, Flu & Cough Remedies. Its NAICS code is 339113 and its SIC code is 5122.